Pharmaceutical Investing Aquinox Announces Topline Results of Phase 3 LEADERSHIP 301 Clinical Trial in Interstitial Cystitis/Bladder Pain Syndrome
Significant intercepts of gold and copper show Golden Eye emerging as a highly promising new resource prospect
Alvopetro Announces an Operational Update, Q1 2025 Financial Results and Details for our Upcoming AGM
Grande Portage Stakes Added Claims to Accommodate Potential Surface Facilities at the New Amalga Gold Project
